Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.01
98% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.2M | $2.4M | $2.3M | $1.1M | $1.2M | $1.0M | $890.9K | $3.1M |
| Cost of revenue | $297.2K | $633.5K | $925.6K | $346.3K | $677.4K | $684.7K | $555.5K | $1.7M |
| Gross profit | $939.9K | $1.8M | $1.4M | $710.5K | $508.0K | $348.3K | $335.5K | $1.4M |
| Gross margin | 76.0% | 74.0% | 59.8% | 67.2% | 42.9% | 33.7% | 37.7% | 46.1% |
| R&D | $176.1K | $642.5K | $161.3K | $480.9K | $649.7K | $1.7M | $4.2M | $3.4M |
| Operating income | −$3.9M | −$5.3M | −$6.0M | −$6.6M | −$14.3M | −$13.7M | −$12.6M | −$8.7M |
| EBITDA | −$3.6M | −$4.6M | −$5.2M | −$5.8M | −$13.5M | −$12.8M | −$11.2M | −$7.6M |
| Net income | −$4.0M | −$5.5M | −$6.1M | −$6.5M | −$14.0M | −$13.9M | −$11.9M | −$8.5M |
| Net margin | -319.9% | -223.6% | -265.2% | -618.4% | -1182.4% | -1346.1% | -1334.0% | -276.4% |
| EPS (diluted) | -0.14 | -0.08 | -0.06 | -0.04 | -0.07 | -0.07 | -0.06 | -0.01 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $6M | $-0.01 | $-0.01–$-0.01 | 1 |
| 2027 | $17M | $-0.01 | $-0.01–$-0.01 | 1 |
| 2028 | $33M | $0.00 | $0.00–$0.00 | 1 |
Forward consensus · source: Financial Modeling Prep
POLAREAN IMAGING LTD
No one on the platform currently holds PLLWF.
No tracked institution reports a position in PLLWF as of their last filing.
No one on the platform has traded PLLWF yet.
| $3M |
| — |
| NRPRResilient Healthcare Corp | $0.02 | +0.00% | $2M | — |
| NUMDNu-Med Plus, Inc. | $0.01 | -0.45% | $914856 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.8× sales vs its 98.2× historical median P/S.
Fair value ≈ $0.82 · price $0.01 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.